Scotchbond Universal Plus Adhesive for Class V Non-carious Cervical Dental Lesions

Phase-Based Progress Estimates
Louisiana State University HSC-Health, School of Dentistry, New Orleans, LA
Class V Non-carious Cervical Dental Lesions
Scotchbond Universal Plus Adhesive - Device
All Sexes
What conditions do you have?

Study Summary

This trial will compare two dental adhesives to see which works better with Filtek restorative material on Class-V non-carious cervical lesions. The Scotchbond Universal Plus Adhesive is used to treat Class V Non-carious Cervical Dental Lesions and has been previously approved by the FDA for a different condition. The treatment can be done online without the use of a placebo.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

0 Primary · 4 Secondary · Reporting Duration: 6 months, 12 months, 24 months

24 months
Incidence of adverse events
Time to restoration failure
Month 24
Post-operative hypersensitivity and tooth vitality
7 days
Baseline post-operative hypersensitivity (subject self-assessment)
Month 12
Marginal Adaptation
Restoration Retention
Month 24
Color match
Fracture of Restorative Material
Marginal staining
Patient satisfaction
Polish retention
Secondary Caries
Surface staining

Trial Safety

Trial Design

2 Treatment Groups

SBU Control Group
1 of 2
SBU+ Treatment Group
1 of 2
Active Control
Experimental Treatment

46 Total Participants · 2 Treatment Groups

Primary Treatment: Scotchbond Universal Plus Adhesive · No Placebo Group · N/A

SBU+ Treatment Group
Experimental Group · 1 Intervention: Scotchbond Universal Plus Adhesive · Intervention Types: Device
SBU Control Group
ActiveComparator Group · 1 Intervention: Scotchbond Universal Adhesive · Intervention Types: Device

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: 6 months, 12 months, 24 months
Closest Location: Louisiana State University HSC-Health, School of Dentistry · New Orleans, LA
Photo of New Orleans 1Photo of New Orleans 2Photo of New Orleans 3
N/AFirst Recorded Clinical Trial
1 TrialsResearching Class V Non-carious Cervical Dental Lesions
0 CompletedClinical Trials

Who is running the clinical trial?

3MLead Sponsor
143 Previous Clinical Trials
30,971 Total Patients Enrolled
John Burgess, DDS, MSPrincipal InvestigatorLouisiana State University HSC Health, School of Dentistry

Eligibility Criteria

Age 18+ · All Participants · 8 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
A person who is not devitalized is able to give informed consent.
You are at least 18 years of age at the time of consent.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.